MedTrace Logo

Initial Development and Dissemination of OC-Go

NCT03126305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2020-11-18

No results posted yet for this study

Summary

The clinical component of Phase I application development examines the clinical utility, feasibility, and functionality of the OC-Go application via an 8-month pilot trial consisting of 50 standard CBT sessions augmented with OC-Go in OCD-diagnosed children who are receiving treatment through the pediatric OCD treatment programs in the UCLA Division of Child and Adolescent Psychiatry

Conditions

  • Obsessive-Compulsive Disorder

Interventions

OTHER

OC-Go

OC-Go, a HIPAA-compliant web-based clinician portal and patient-side mobile application that allows clinicians to create and push tailored treatment assignments to patients on their mobile devices

Sponsors & Collaborators

Principal Investigators

  • John Piacentini, Ph.D. · University of California, Los Angeles

  • Peter Tuerk, Ph.D. · Virtually Better, Inc.

Eligibility

Min Age
9 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03126305 on ClinicalTrials.gov